1-1 of 1
Keywords: Prospective study on cancer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Tolerability of Leuprorelin Acetate (Eligard®) in Daily Practice in Germany: Pooled Data from 2 Prospective, Non-Interventional Studies with 3- or 6-Month Depot Formulations in Patients with Advanced Prostate Cancer

Available to Purchase
Subject Area:
Further Areas
Carsten-Henning Ohlmann, Marco Gross-Langenhoff
Journal: Urologia Internationalis
Urol Int (2018) 100 (1): 66–71.
https://doi.org/10.1159/000479187
Published Online: 01 December 2017
... from any ideas, methods, instructions or products referred to in the content or advertisements. Eligard® Leuprolide Non-interventional studies Prospective study on cancer In Germany, prostate cancer is the most prevalent cancer in men (26%), with an incidence of 66,900 new cases...
View article titled, Efficacy and Tolerability of Leuprorelin Acetate (Eligard®) in Daily Practice in Germany: Pooled Data from 2 Prospective, Non-Interventional Studies with 3- or 6-Month Depot Formulations in Patients with Advanced Prostate Cancer
Open the PDF for Efficacy and Tolerability of Leuprorelin Acetate (Eligard®) in Daily Practice in Germany: Pooled Data from 2 Prospective, Non-Interventional Studies with 3- or 6-Month Depot Formulations in Patients with Advanced Prostate Cancer in another window